RheumPAC Announces New Donor Benefits in 2020
Donors at each giving level will receive recognition and special benefits at the ACR’s 2020 annual meeting. (Source: The Rheumatologist)
Source: The Rheumatologist - February 20, 2020 Category: Rheumatology Authors: From the College Tags: Legislation & Advocacy donation RheumPAC Source Type: research

15% E/M Services Reimbursement Hike a Win for Rheumatology
ACR advocacy leaders are celebrating a 15% planned increase in reimbursement for rheumatology evaluation and management services and are calling on members to thank Congress. (Source: The Rheumatologist)
Source: The Rheumatologist - February 20, 2020 Category: Rheumatology Authors: Carina Stanton Tags: Legislation & Advocacy evaluation and management (E/M) codes Physician fee schedule Source Type: research

Changes & Additions to RISE Measures in 2020
Using RISE? Check out the updates for 2020, including five new measures available only through the RISE registry. (Source: The Rheumatologist)
Source: The Rheumatologist - February 20, 2020 Category: Rheumatology Authors: From the College Tags: Practice Management Rheumatology Informatics System for Effectiveness (RISE) Registry Source Type: research

Increasing Opioid Dose May Not Help Chronic Pain
NEW YORK (Reuters Health)—In patients with chronic musculoskeletal pain, an increase in opioid dosage appears to be of no clear benefit, according to a two-year study. As Benjamin J. Morasco, PhD, tells Reuters Health by email, “When we followed patients with chronic pain, who were already prescribed long-term opioid therapy, we found patients as a... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 19, 2020 Category: Rheumatology Authors: David Douglas Tags: Analgesics Drug Updates Source Type: research

Low-Dose Methotrexate Can Cause Adverse Effects
NEW YORK (Reuters Health)—Low-dose methotrexate can be associated with gastrointestinal, pulmonary, infectious, hematologic and other adverse effects, according to an analysis of the Cardiovascular Inflammation Reduction Trial (CIRT). “Methotrexate is not a benign drug, even at dosages used for rheumatic diseases,” Daniel H. Solomon, MD, MPH of Brigham and Women’s Hospital, Boston, tells Reuters Health... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 19, 2020 Category: Rheumatology Authors: Will Boggs, MD Tags: DMARDs & Immunosuppressives Drug Updates adverse events Methotrexate Source Type: research

FDA Advisory Committees Reject Oxycodegol (NKTR-181) Application
FDA advisory committees rejected the new drug application for oxycodegol, an opioid analgesic, due to a lack of data regarding it’s potential for abuse... (Source: The Rheumatologist)
Source: The Rheumatologist - February 19, 2020 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Analgesics Drug Updates FDA NKTR-181 opioid oxycodegol Pain Management U.S. Food and Drug Administration (FDA) Source Type: research

10 Characteristics of Good Mentoring: Tips for What Mentees Need from Their Mentors
Antony Rosen, MBChB, describes the 10 essential characteristics of good mentorship... (Source: The Rheumatologist)
Source: The Rheumatologist - February 19, 2020 Category: Rheumatology Authors: Thomas R. Collins Tags: Career Development Professional Topics 2019 ACR/ARP Annual Meeting Career tips Mentoring Mentorship Source Type: research

Sodium-Glucose Cotransporter-2 Inhibitors May Decrease Gout Risk in Some Patients
Recent research assessed the risk of gout in patients with type 2 diabetes mellitus prescribed sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with those prescribed a glucagon-like peptide-1 (GLP-1) agonist. The study found patients on the SGLT2 inhibitor had a lower rate of gout, suggesting SGLT2 inhibitors may actually reduce the risk of gout among this patient population... (Source: The Rheumatologist)
Source: The Rheumatologist - February 19, 2020 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Crystal Arthritis Gout SGLT2 inhibitors sodium-glucose cotransporter-2 (SGLT2) inhibitors type II diabetes Source Type: research

Coding Corner Answers: Using NP/PA Services in Practice
Take the challenge. Scenario 1—A: The nurse practitioner may act as the supervising physician if it’s within the scope of practice for the NP and should be coded as follows: CPT: 96413, 96415, J1745 x 30, J1200 x 1 Diagnosis ICD:10: M05.79 Scenario 2—A: To qualify as an incident-to service, the PA can provide the... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: From the College Tags: Billing/Coding From the College Medicare nurse practitioner physician assistant Source Type: research

Coding Corner Questions: Using NP/PA Services in Practice
Scenario 1: Direct Billing A 70-year-old female patient with rheumatoid arthritis in multiple joints and positive rheumatoid factor returns to the practice for her fourth infusion of infliximab with the nurse practitioner (NP). She reports no fevers, cough, dyspnea or concurrent illness. She rates the severity of her joint pain at 6 on a 10-point... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: From the College Tags: Billing/Coding From the College Medicare nurse practitioner physician assistant Source Type: research

Don ’t Miss 2020 E/M Coding Workshop in New Orleans
Access to good training and education on practice management and coding issues has proved beneficial to physician success. Getting up-to-date information on compliance, insurance reimbursement, office efficiency, coding and billing is crucial for effective and efficient practice management. The ACR’s Committee on Rheumatologic Care (CORC) has created the premier one-day E/M Documentation Trends and Best... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: From the College Tags: Billing/Coding From the College Practice Management E/M Coding Source Type: research

VERA Aims to Expand Rheumatology Care for the Underserved
The ACR’s Volunteers to Expand Rheumatology Access (VERA) initiative recently launched a new webpage to provide helpful information to rheumatology healthcare providers interested in volunteering to care for uninsured and under­insured patients with rheumatic disease. This resource, VolunteerRheumCare.org, provides answers to frequently asked questions related to providing free care, as well as links to organizations... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: From the College Tags: From the College Volunteering Volunteers to Expand Rheumatology Access (VERA) Source Type: research

The Rheumatology Research Foundation Welcomes New Leaders
The Rheumatology Research Foundation has appointed S. Louis Bridges Jr., MD, PhD, to serve as president for a two-year term. Dr. Bridges has served as the director of the University of Alabama–Birmingham (UAB) Division of Clinical Immunology and Rheumatology since 2009. He is also the director of the UAB Comprehensive Arthritis, Musculo­skeletal, Bone and Autoimmunity... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: From the College Tags: From the College Dr. Douglas White Dr. Louis Bridges Jr. Dr. V. Michael Holers Dr. Vikas Majithia Rheumatology Research Foundation Source Type: research

Proposed Changes May Loosen Federal Fraud & Abuse Laws
The Stark law and the Anti-Kickback Statute (AKS) are the U.S. healthcare system’s primary fraud and abuse laws, and highly anticipated proposed reform plans from the Centers for Medicare & Medicaid Services (CMS) and the Office of Inspector General (OIG) were finally unveiled on Oct. 17, 2019. The proposed reforms would 1) clarify certain requirements... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: Steven M. Harris, Esq. Tags: Legal Anti-Kickback Statute Centers for Medicare and Medicaid Services (CMS) Stark Law Source Type: research

5 Challenges in the Treatment & Diagnosis of Lupus
A recent study published in Lupus Science & Medicine lays out five of the top barriers impeding progress in lupus diagnosis and treatment.1 The Addressing Lupus Pillars for Health Advancement project (ALPHA), led by the Lupus Foundation of America (LFA), researchers at the Tufts School of Medicine Center for the Study of Drug Development (Tufts... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: Kelly Tyrrell Tags: Conditions Research Reviews SLE (Lupus) Access to care adherence Biomarkers clinical trials heterogeneity Socioeconomic Impact Source Type: research

How to Diagnose Upper Extremity Injuries
ATLANTA—Two ways to investigate injuries to the upper extremities are by in-depth physical examinations and ultrasound. In a Clinical Practice session at the 2019 ACR/ARP Annual Meeting, Anatomy: Correlating Physical Exam and Ultrasound in Common Sports Injuries of the Upper Extremity, Carlin Senter, MD, FACP, associate professor of primary care sports medicine at the University... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: Mike Fillon Tags: 2019 ACR/ARP Annual Meeting Conditions physical exam sports medicine Ultrasound upper extremity injuries Source Type: research

From Chronic Low Back Pain to Axial Spondyloarthritis
ATLANTA—The potential of cannabis‐based medicines is a hot topic, particularly as pain management therapy for arthritis and other conditions. However, confusion abounds regarding its therapeutic potential, how it can be administered and even the correct terminology to use. David P. Finn, PhD, professor of pharma­cology and therapeutics, and founding co-director of the Centre for Pain... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: Mike Fillon Tags: 2019 ACR/ARP Annual Meeting Conditions Spondyloarthritis Axial Spondyloarthritis chronic low-back pain HLA-B27 Source Type: research

Tactics for Bolstering the Rheumatology Workforce
ATLANTA—The rheumatology profession faces a severe shortfall of practitioners that threatens the ability to address patients’ needs. “Even if we doubled the number of positions for fellowship training, we wouldn’t meet the increasing demand on our workforce,” said Marcy B. Bolster, MD, associate professor of medicine at Harvard Medical School, Boston, and director of the... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 13, 2020 Category: Rheumatology Authors: Mike Fillon Tags: 2019 ACR/ARP Annual Meeting Practice Management Advanced Practice Clinicians nurse practitioner physician assistant telemedicine workforce shortage Source Type: research

Range of Insurance Issues Challenge Rheumatology
ACR representatives updated members on recent insurance issues... (Source: The Rheumatologist)
Source: The Rheumatologist - February 12, 2020 Category: Rheumatology Authors: Thomas R. Collins Source Type: research

A Public Health Approach to Arthritis: Experts Continue to Raise Awareness of Arthritis Burden
Public health agencies have been raising the profile of arthritis... (Source: The Rheumatologist)
Source: The Rheumatologist - February 12, 2020 Category: Rheumatology Authors: Thomas R. Collins Tags: Professional Topics Arthritis burden CDC public health Source Type: research

FDA Rheumatology Update: New Drug Approvals, Plus Expanded Drug Indications & Safety Concerns
Last year, the FDA was busy with new biologic and other drug approvals, new and expanded drug indications, and important safety updates relevant to rheumatology... (Source: The Rheumatologist)
Source: The Rheumatologist - February 12, 2020 Category: Rheumatology Authors: Susan Bernstein Tags: Drug Updates 2019 ACR/ARHP Annual Meeting Biologics FDA U.S. Food and Drug Administration (FDA) Source Type: research

Coverage & Reimbursement Challenges: Updates from the ACR Insurance Subcommittee Chair
The ACR Insurance Subcommittee is working to address specialty pharmacy requirements for in-office treatments, elimination of consultation codes and other coverage and reimbursement challenges. (Source: The Rheumatologist)
Source: The Rheumatologist - February 7, 2020 Category: Rheumatology Authors: Chris Phillips, MD Tags: Billing/Coding Legislation & Advocacy ACR Insurance Subcommittee (ISC) Consultation Codes Dr. Chris Phillips modifier 25 specialty drug acquisition Source Type: research

Are Your Patients at Risk? Advocacy Matters
When insurance company practices put patients at risk, advocacy is an important tool physicians can use to make a real difference. You can make a difference. (Source: The Rheumatologist)
Source: The Rheumatologist - February 6, 2020 Category: Rheumatology Authors: Kimberly Retzlaff Tags: Legislation & Advocacy ACR Insurance Subcommittee (ISC) Brian Loggins Chris Morris Dr. Chris Phillips Government Affairs Committee (GAC) Norman B. Gaylis Source Type: research

Evaluation & Management Code Changes Set for 2021
Major changes to office and outpatient evaluation and management codes 99201–99205 and 99211–99215 will take effect Jan. 1, 2021. (Source: The Rheumatologist)
Source: The Rheumatologist - February 6, 2020 Category: Rheumatology Authors: From the College Tags: Billing/Coding evaluation and management (E/M) Source Type: research

Washington Legislature Introduces Student Loan Forgiveness Bill
A bill introduced in January in the Washington Legislature would allow pediatric and juvenile rheumatologists to access the state’s loan forgiveness program. (Source: The Rheumatologist)
Source: The Rheumatologist - February 6, 2020 Category: Rheumatology Authors: Joseph Cantrell, JD Tags: Education & Training Professional Topics Joseph Cantrell loan forgiveness Pediatric Rheumatology Source Type: research

According to MRI, Ultrasound Guidance Does Not Improve Treat-to-Target in RA
NEW YORK (Reuters Health)—Ultrasound guidance does not improve the effectiveness of treat-to-target therapy in rheumatoid arthritis (RA), new findings confirm. “Incorporating ultrasound information in treatment decisions did not lead to reduced MRI inflammation or less structural damage compared with a conventional treatment strategy,” Dr. Ulf Sundin of Diakonhjemmet Hospital, Oslo, and colleagues write in Rheumatology.... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 6, 2020 Category: Rheumatology Authors: Reuters Staff Tags: Conditions Rheumatoid Arthritis imaging Magnetic resonance imaging (MRI) Rheumatoid Arthritis (RA) Treat-to-Target Ultrasound Source Type: research

In Memoriam: Calvin R. Brown Jr., MD
Calvin R. Brown Jr., MD, of Chicago, passed away Dec. 1, 2019. He was 66 years old. In the course of a medical career, you meet dozens of people who impact you in one way or another. Patients, professors, fellow students, colleagues in your practice—all help shape who we become as a physician. Sometimes, though,... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 5, 2020 Category: Rheumatology Authors: Eric Ruderman, MD Tags: Profiles Brown Source Type: research

Risankizumab Demonstrates Superiority to Secukinumab for Plaque Psoriasis
In a phase 3, comparator study in adults with plaque psoriasis, patients taking risankizumab achieved greater skin clearance than those taking secukinumab... (Source: The Rheumatologist)
Source: The Rheumatologist - February 5, 2020 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates plaque psoriasis risankizumab secukinumab Source Type: research

Even with Insurance, Fewer Americans Seeing Primary Care Providers
(Reuters Health)—Almost half of U.S. adults with private health insurance are not visiting primary care providers for routine care or sick visits, a new study suggests. Between 2008 and 2016, the number of annual primary care visits for every 100 people with private health insurance declined by 22%, from 169.5 to 134.3, the study found.... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - February 4, 2020 Category: Rheumatology Authors: Lisa Rapaport Tags: Professional Topics Source Type: research

Varicella Zoster Virus Not Associated with Giant Cell Arteritis Pathogenesis
Researchers suggest antiviral therapy is not appropriate for patients with GCA, based on their study findings and related research... (Source: The Rheumatologist)
Source: The Rheumatologist - February 4, 2020 Category: Rheumatology Authors: Carina Stanton Tags: Conditions Vasculitis GCA giant cell arteritis (GCA) varicella zoster virus Source Type: research

Update on the Management of Takayasu Arteritis
A rare form of large vessel vasculitis, Takayasu arteritis persents with no clear patterns, with patients experiencing vascular symptoms, as well as such systemic symptoms as fever and weight loss. A systematic literature review found evidence to guide rheumatologists in monitoring and treating their patients with Takayasu arteritis... (Source: The Rheumatologist)
Source: The Rheumatologist - February 4, 2020 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Vasculitis large-vessel vasculitis Takayasu’s Arteritis Source Type: research

Biologic Spending & Price Trends
Any given rheumatology patient who needs a biologic disease-modifying anti-rheumatic drug (DMARD) will spend $22,000–44,000 on their medication each year... (Source: The Rheumatologist)
Source: The Rheumatologist - January 28, 2020 Category: Rheumatology Authors: Arthritis & Rheumatology Tags: Biologics & Biosimilars Drug Updates adalimumab biologic drugs Disease-modifying antirheumatic drugs (DMARDs) etanercept infliximab Source Type: research

Canada & E.U. Approve Upadacitinib for RA
Upadacitinib will soon be available to treat patients with moderate to severe rheumatoid arthritis in Canada and the E.U... (Source: The Rheumatologist)
Source: The Rheumatologist - January 28, 2020 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Biologics & Biosimilars Drug Updates Canada European Union Rheumatoid Arthritis (RA) U.S. Food and Drug Administration (FDA) upadacitinib Source Type: research

The Care & Treatment of Myositis: Creatinine Kinase Level Isn ’t Gospel & Other Recommendations
During a session at the 2019 ACR/ARP Annual Meeting, Lisa Christopher-Stine, MD, MPH, provided valuable recommendations and practical insights into the care and treatment of myositis patients... (Source: The Rheumatologist)
Source: The Rheumatologist - January 28, 2020 Category: Rheumatology Authors: Thomas R. Collins Tags: Conditions 2019 ACR/ARP Annual Meeting myositis Treatment Source Type: research

New Insights into the Management of Giant Cell Arteritis
A systematic literature review identified novel evidence on the treatment and management of GCA that was incorporated into the most recent EULAR recommendations on the management of large vessel vasculitis. Investigators confirmed the efficacy of prompt initiation of glucocorticoids and found fast-track approaches to diagnosis lowered the risk of ischemic complications... (Source: The Rheumatologist)
Source: The Rheumatologist - January 28, 2020 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Vasculitis EULAR GCA giant cell arteritis (GCA) guideline large-vessel vasculitis recommendations tocilizumab Source Type: research

Increased Risk of Inflammatory Arthritis with Hidradenitis Suppurativa
NEW YORK (Reuters Health)—Patients with hidradenitis suppurativa face an increased risk of developing inflammatory arthritis, according to findings from a claims database. “We observed increased risks of developing ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis (RA) among patients with hidradenitis suppurativa when compared with those without hidradenitis suppurativa,” says Maria C. Schneeweiss, MD, of Brigham... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 27, 2020 Category: Rheumatology Authors: Will Boggs, MD Tags: Conditions Hidradenitis suppurativa Inflammatory arthritis risk Spondylarthritis Source Type: research

New Membership & Nominations Chair Dr. Hazel Breland Outlines Goals for ARP Membership Growth
Having completed her term as ARP president, Hazel L. Breland, PhD, OTR/L, FAOTA, CLA, has stepped into a new role as chair of ARP’s Membership & Nominations Committee (https://www.rheumatology.org/Rheumatology-Professionals). Dr. Breland is associate professor of occupational therapy at the Medical University of South Carolina (MUSC), Charleston, where she teaches graduate students and serves as the... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 24, 2020 Category: Rheumatology Authors: Larry Beresford Tags: American College of Rheumatology Professional Topics Volunteering Source Type: research

New Gabapentinoid Warning Labels
Gabapentinoid products will now carry warning labels about the risks of respiratory distress when combined with opioids and other nervous system and respiratory depressants... (Source: The Rheumatologist)
Source: The Rheumatologist - January 23, 2020 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Drug Safety FDA gabapentinoids U.S. Food and Drug Administration (FDA) Source Type: research

The ACR to Host the 22nd PANLAR Pan-American Congress of Rheumatology
The 22nd PANLAR Pan-American Congress of Rheumatology will provide rheumatologists access to a cutting-edge scientific program and the opportunity to meet colleagues from all over the Americas... (Source: The Rheumatologist)
Source: The Rheumatologist - January 22, 2020 Category: Rheumatology Authors: Guillermo Andres Quiceno, MD Tags: Education & Training International Pan American League of Rheumatology Associations (PANLAR) Source Type: research

Support Pediatric Subspecialty Loan Repayment to Boost Workforce Growth
Current legislation that stipulates a loan repayment program for pediatric subspecialists could help the pediatric rheumatology community attract trainees and meet patient demand. (Source: The Rheumatologist)
Source: The Rheumatologist - January 21, 2020 Category: Rheumatology Authors: Tamar Rubinstein, MD, MS Tags: Education & Training Workforce ACR Workforce Study Government Affairs Committee (GAC) loan repayment Pediatric Rheumatology workforce development Source Type: research

Pragmatic Language Dysfunction in SLE
A recent study is the first to examine pragmatic language skills in patients with systemic lupus erythematosus (SLE), finding that approximately half of SLE patients have pragmatic language dysfunction... (Source: The Rheumatologist)
Source: The Rheumatologist - January 20, 2020 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions SLE (Lupus) language dysfunction pragmatic language systemic lupus erythematosus (SLE) Source Type: research

How to Work with Sales & Marketing Representatives in Your Practice
Sales and marketing representatives can add tremendous value to your practice: They can generate consistent business by leveraging contacts who have services that can be referred to your practice. However, the services a sales and marketing representative provides are subject to significant scrutiny under the federal Anti-Kickback Statute and state equivalents. For this reason, the... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 17, 2020 Category: Rheumatology Authors: Steven M. Harris, Esq. Tags: Legal Practice Management Anti-Kickback Statute Eliminating Kickbacks in Recovery Act (EKRA) Source Type: research

Tips for Smoothing the Time-Consuming Prior Authorization Process
ATLANTA—Obtaining prior authorization to ensure services or prescription drugs are covered by a patient’s health plan consumes staff time, and delays or denials may cause patients to abandon treatment, according to speakers at the 2019 ACR/ARP Annual Meeting. In a session on Nov. 10, the experts shared tips to smooth the process. Train Staff on... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 17, 2020 Category: Rheumatology Authors: Susan Bernstein Tags: Practice Management Workforce 2019 ACR/ARP Annual Meeting pharmacy benefit managers (PBMs) prior authorization step therapy Source Type: research

Clinical Pearls for Diagnosing & Treating Sj ögren’s Syndrome
ATLANTA—Dry eyes and mouth are common symptoms in the general population. When patients report these symptoms to their primary care provider and other consultants, it may prompt a referral to a rheumatologist to rule out Sjögren’s syndrome. However, as discussed in the 2019 ACR/ARP Annual Meeting session, Sjögren’s Syndrome: Beyond the Dryness, evaluation of this... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 17, 2020 Category: Rheumatology Authors: Jason Liebowitz, MD Tags: Conditions 2019 ACR/ARP Annual Meeting Sjogren's syndrome Source Type: research

Tips for Exploring Tough Topics with Teens with Rheumatic Disease
ATLANTA—Managing teenage patients may present challenges for pediatric rheumatologists and rheumatology professionals not only because of their often complex, rare conditions, but because teenagers are, well, teenagers. Teens may experiment with sexual intercourse, alcohol use, tobacco or vaping e-cigarettes to fit in with their peers, even if these habits have serious health consequences, according to... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 17, 2020 Category: Rheumatology Authors: Susan Bernstein Tags: Patient Perspective President's Perspective 2019 ACR/ARP Annual Meeting Pediatric Rheumatology Source Type: research

Emerging Biomarkers for Lupus
ATLANTA—When it comes to identifying reliable biomarkers that can predict worsening illness or help point to proper treatment, it’s hard to imagine a more vexing disease than systemic lupus erythematosus (SLE), said Jill P. Buyon, MD, director of the Lupus Center at New York University Langone Medical Center, in the 2019 ACR/ARP Annual Meeting session... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 17, 2020 Category: Rheumatology Authors: Thomas R. Collins Tags: Conditions SLE (Lupus) 2019 ACR/ARP Annual Meeting Biomarkers Research Source Type: research

Tips for Engaging Your Pediatric Research Patients
ATLANTA—Around 2002, when Vincent Del Gaizo’s son was just 15 months old, he was hospitalized in an intensive care unit and, weeks later, was diagnosed with systemic juvenile idiopathic arthritis (JIA). “We had the same 8 trillion questions that all parents have when their child is diagnosed with a condition you’ve never heard of: ‘Is... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 17, 2020 Category: Rheumatology Authors: Susan Bernstein Tags: Patient Perspective Professional Topics 2019 ACR/ARP Annual Meeting Childhood Arthritis and Rheumatology Research Alliance Patient-Centered Outcomes Research Institute (PCORI) Pediatric-Rheumatology Care and Outcome Improvement Network (PR-COIN) Source Type: research

What Should Providers Do to Address Polypharmacy?
ATLANTA—In a session at the 2019 ACR/ARP Annual Meeting, Susan Chrostowski, DNP, assistant clinical professor at Texas Woman’s University College of Nursing, Dallas, told the audience that she’d had a visit with a patient and asked how he was doing. “Not too good,” he said, explaining that his chest hurt. “What’s the matter with your... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 17, 2020 Category: Rheumatology Authors: Thomas R. Collins Tags: Patient Perspective 2019 ACR/ARP Annual Meeting adherence Centers for Medicare & Medicaid Services Medication Theraphy Management polypharmacy Source Type: research

Tele-Rheumatology Offers Lots of Benefits
ATLANTA—With growing demand for access to rheumatologists in rural areas, a shortage in the number of rheumatologists and the ability to use technology as a bridge to patients in remote areas, telemedicine seems like a smart option. And it certainly can be, experts said at a 2019 ACR/ARP Annual Meeting session in November. But a... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 17, 2020 Category: Rheumatology Authors: Thomas R. Collins Tags: Practice Management Technology 2019 ACR/ARP Annual Meeting telemedicine Source Type: research

A Report from 2 ACR/EULAR Exchange Participants
Since 1998, the ACR/European League Against Rheumatism (EULAR) Exchange Program has supported junior academic rheumatologists, rheumatology professionals and health professionals in rheumatology in traveling from Europe to the U.S., and vice versa, to exchange clinical and research skills, expertise and knowledge. The program is designed to recognize outstanding early career faculty in rheumatology research, so... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - January 17, 2020 Category: Rheumatology Authors: Ioannis Parodis, MD, PhD, & Katie Druce, PhD Tags: Career Development Education & Training ACR/EULAR Exchange Program Source Type: research